LONDON, April 3, 2018 /PRNewswire/ --
David F Chang; US Ophthalmic Review, 2017;10(2):95-8 DOI: https://doi.org/10.17925/USOR.2017.10.02.95
Published recently in US Ophthalmic Review, the peer-reviewed journal from touchOPHTHALMOLOGY, David Chang discusses adjustable intraocular lenses (IOLs) are uniquely poised to disrupt the refractive IOL arena for both cataract and refractive lens exchange patients. This is because they will not only improve refractive outcomes, but will dramatically enhance the patient experience as well. Patients will be able to postpone confusing decisions about refractive targets and objectives until they can preview them postoperatively. The unique benefit of being able to customize and "choose" their pseudophakic vision after the surgery will be understandable, desirable, and easily explained to family and friends.
The full article is available here:
Disclosure: David F Chang is a consultant for RxSight, Powervision, J&J Vision, and Zeiss. No funding was received in the publication of this article. This article is a short opinion piece and has not been submitted to external peer reviewers.
touchOPHTHALMOLOGY (a division of Touch Medical Media) publishes the US Ophthalmic Review, a peer-reviewed, open access, bi-annual journal specialising in the publication of balanced and comprehensive review articles written by leading authorities to address the most important and salient developments in the field of ophthalmology. The aim of these reviews is to break down the high science from 'data-rich' primary papers and provide practical advice and opinion on how this information can help physicians in the day to day clinical setting. Practice guidelines, symposium write-ups, case reports, and original research articles are also featured to promote discussion and learning amongst physicians, clinicians, researchers and related healthcare professionals.
"Touch Medical Media is a trading name of Touch Digital Media Limited, a private limited company registered in England and Wales at The White House Mill Road, Goring, Reading, England, RG8 9DD with registered number 08197142".
For inquires please contact:
Nicola Cartridge - Editorial Director
"Leading the Debate on the Advances in Healthcare"